Search
for
Sort by
Research 391–420 of 970
- Serum Levels of Retinol-Binding Protein 4 and Adiponectin in Women with Polycystic Ovary Syndrome: Associations with Visceral Fat But No Evidence for Fat Mass-Independent Effects on Pathogenesis in This Condition
- Are sex discordant outcomes in COVID-19 related to sex hormones?
- Evidence for Increased 5α-Reductase Activity During Early Childhood in Daughters of Women With Polycystic Ovary Syndrome
- Low sex-hormone binding globulin levels in young women with diffuse hair loss
- Non polycystic ovary syndrome–related endocrine disorders associated with hirsutism
- The effect of weight loss and treatment with metformin on serum vaspin levels in women with polycystic ovary syndrome
- Redefining hormone resistance in prostate cancer
- Sexuality in premature ovarian insufficiency
- Gender-Affirming Hormone Therapy for Transgender Females
- ANTIANDROGEN THERAPY IN DERMATOLOGY
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- Clinical relevance of testosterone and dihydrotestosterone metabolism in women
- Manifestation of Hyperandrogenism in the Continuous Light Exposure-Induced PCOS Rat Model
- Characteristics of flutamide action on prostatic and testicular functions in the rat
- Diagnostic approach to low‐renin hypertension
- Becker's Nevus with Ipsilateral Breast Hypoplasia: Improvement with Spironolactone
- Novel agents for the treatment of alopecia
- Gender-Affirming Hormone Therapy for Transgender Men
- 12 Treatment of hirsutism with 5α-reductase inhibitors
- Androgen antagonists in androgen target tissues
- Synaptic Long-Term Potentiation and Depression in the Rat Medial Vestibular Nuclei Depend on Neural Activation of Estrogenic and Androgenic Signals
- Contribution of androgens to chronic allograft nephropathy is mediated by dihydrotestosterone
- Interventions for morphea
- Hormone therapy in acne
- Male hormonal contraception: looking back and moving forward
- The Pathogenesis of Alopecia Areata in Rodent Models
- Long-term dutasteride therapy in men with benign prostatic hyperplasia alters glucose and lipid profiles and increases severity of erectile dysfunction
- Finasteride, not tamsulosin, increases severity of erectile dysfunction and decreases testosterone levels in men with benign prostatic hyperplasia
- Are there temporal subtypes of premenstrual dysphoric disorder?: using group-based trajectory modeling to identify individual differences in symptom change
- COVID-19 and andrology: Recommendations of the French-speaking society of andrology (Société d’Andrologie de langue Française SALF)